Literature DB >> 25639646

NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells.

Kritarth Singh1, Anastasia Poteryakhina2, Andrei Zheltukhin2, Khyati Bhatelia1, Paresh Prajapati1, Lakshmi Sripada1, Dhanendra Tomar3, Rochika Singh3, Arun K Singh3, Peter M Chumakov4, Rajesh Singh5.   

Abstract

Chronic inflammation in tumor microenvironment plays an important role at different stages of tumor development. The specific mechanisms of the association and its role in providing a survival advantage to the tumor cells are not well understood. Mitochondria are emerging as a central platform for the assembly of signaling complexes regulating inflammatory pathways, including the activation of type-I IFN and NF-κB. These complexes in turn may affect metabolic functions of mitochondria and promote tumorigenesis. NLRX1, a mitochondrial NOD-like receptor protein, regulate inflammatory pathways, however its role in regulation of cross talk of cell death and metabolism and its implication in tumorigenesis is not well understood. Here we demonstrate that NLRX1 sensitizes cells to TNF-α induced cell death by activating Caspase-8. In the presence of TNF-α, NLRX1 and active subunits of Caspase-8 are preferentially localized to mitochondria and regulate the mitochondrial ROS generation. NLRX1 regulates mitochondrial Complex I and Complex III activities to maintain ATP levels in the presence of TNF-α. The expression of NLRX1 compromises clonogenicity, anchorage-independent growth, migration of cancer cells in vitro and suppresses tumorigenicity in vivo in nude mice. We conclude that NLRX1 acts as a potential tumor suppressor by regulating the TNF-α induced cell death and metabolism.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Caspase-8; Inflammation; Metabolic reprogramming; Mitochondria; NLRX1

Mesh:

Substances:

Year:  2015        PMID: 25639646     DOI: 10.1016/j.bbamcr.2015.01.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Immunometabolic rewiring of tubular epithelial cells in kidney disease.

Authors:  Sanne van der Rijt; Jaklien C Leemans; Sandrine Florquin; Riekelt H Houtkooper; Alessandra Tammaro
Journal:  Nat Rev Nephrol       Date:  2022-07-07       Impact factor: 42.439

2.  Loss of NLRX1 Exacerbates Neural Tissue Damage and NF-κB Signaling following Brain Injury.

Authors:  Michelle H Theus; Thomas Brickler; Armand L Meza; Sheryl Coutermarsh-Ott; Amanda Hazy; Denis Gris; Irving C Allen
Journal:  J Immunol       Date:  2017-10-09       Impact factor: 5.422

Review 3.  Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.

Authors:  Sheryl Coutermarsh-Ott; Kristin Eden; Irving Coy Allen
Journal:  J Gen Virol       Date:  2016-01-13       Impact factor: 3.891

4.  Enforced lysosomal biogenesis rescues erythromycin- and clindamycin-induced mitochondria-mediated cell death in human cells.

Authors:  Rochika Singh; Rajesh Singh; Paresh Prajapati; Pooja Dalwadi; Dhruv Gohel; Kritarth Singh; Lakshmi Sripada; Khyati Bhatelia; Bhavana Joshi; Milton Roy; Wang-Xia Wang; Joe E Springer
Journal:  Mol Cell Biochem       Date:  2019-07-15       Impact factor: 3.842

5.  Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.

Authors:  Mingyang Han; Yucheng Song; Xuedong Zhang
Journal:  Pharmacogn Mag       Date:  2016-05-11       Impact factor: 1.085

6.  Down-Regulating Receptor Interacting Protein Kinase 1 (RIP1) Promotes Oxaliplatin-Induced Tca8113 Cell Apoptosis.

Authors:  BaoZhong Shan; Feng Ma; MingGuo Wang; Xin Xu
Journal:  Med Sci Monit       Date:  2015-10-13

7.  NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity.

Authors:  Geurt Stokman; Lotte Kors; Pieter J Bakker; Elena Rampanelli; Nike Claessen; Gwendoline J D Teske; Loes Butter; Harmen van Andel; Marius A van den Bergh Weerman; Per W B Larsen; Mark C Dessing; Coert J Zuurbier; Stephen E Girardin; Sandrine Florquin; Jaklien C Leemans
Journal:  J Exp Med       Date:  2017-06-16       Impact factor: 14.307

8.  NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.

Authors:  Sheryl Coutermarsh-Ott; Alysha Simmons; Vittoria Capria; Tanya LeRoith; Justin E Wilson; Bettina Heid; Casandra W Philipson; Qizhi Qin; Raquel Hontecillas-Magarzo; Josep Bassaganya-Riera; Jenny P-Y Ting; Nikolaos Dervisis; Irving C Allen
Journal:  Oncotarget       Date:  2016-05-31

Review 9.  NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions.

Authors:  Nidhi Sharma; Sushmita Jha
Journal:  Cell Mol Life Sci       Date:  2015-12-26       Impact factor: 9.207

10.  NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway.

Authors:  Haiyan Yin; Gaoying Sun; Qianqian Yang; Chen Chen; Qi Qi; Haibo Wang; Jianfeng Li
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.